Received Jun 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 9532Y | — |
Boostrix less than 30 days expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 20-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 9532Y, expiry date 23-MAY-2025) for prophylaxis. On 16-JUN-2025, the patient received the 4th dose of Boostrix. On 16-JUN-2025, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Boostrix less than 30 days expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 16-JUN-2025 A nurse manager wanted to know how to proceed after giving an expired dose of Boostrix (05.23.25) on 16th Jun 2025 (less than 30 days between both dates) which led to expired vaccine use. It was the fourth dose in the immunization schedule and the second o Boostrix that the patient received